GENTEX CORP
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
GNTX$19.42-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Shareholders' Investment
| Common StockShares | Common StockAmount | Additional Paid-InCapital | Retained Earnings | Accumulated OtherComprehensiveIncome (Loss) | Total | Equity Attributable to Noncontrolling Interests | Total Shareholders’Investment | |
|---|---|---|---|---|---|---|---|---|
| BALANCE AS OF JANUARY 1, 2025 | 227,207,472 | $13,632,448 | $1,010,440,420 | $1,450,287,128 | $(6,409,341) | $2,467,950,655 | $4,149,000 | $2,472,099,655 |
| Issuance of common stock from stock plan transactions | 709,996 | 42,600 | 4,891,102 | — | — | 4,933,702 | — | 4,933,702 |
| Repurchases of common stock | (3,100,351) | (186,021) | (12,246,386) | (63,573,666) | — | (76,006,073) | — | (76,006,073) |
| Stock-based compensation expense related to stock options, employee stock purchases and restricted stock | — | — | 8,671,763 | — | — | 8,671,763 | — | 8,671,763 |
| Dividends declared ($0.12 per share) | — | — | — | (26,977,308) | — | (26,977,308) | — | (26,977,308) |
| Capital contributions, net | — | — | — | — | — | — | 442,500 | 442,500 |
| Net income | — | — | — | 94,874,045 | — | 94,874,045 | — | 94,874,045 |
| Other comprehensive income | — | — | — | — | 1,379,219 | 1,379,219 | — | 1,379,219 |
| BALANCE AS OF MARCH 31, 2025 | 224,817,117 | $13,489,027 | $1,011,756,899 | $1,454,610,199 | $(5,030,122) | $2,474,826,003 | $4,591,500 | $2,479,417,503 |
| BALANCE AS OF JANUARY 1, 2024 | 231,455,443 | $13,887,326 | $968,245,875 | $1,336,940,990 | $(6,557,122) | $2,312,517,069 | $— | $2,312,517,069 |
| Issuance of common stock from stock plan transactions | 944,345 | 56,661 | 16,777,325 | — | — | 16,833,986 | — | 16,833,986 |
| Repurchases of common stock | (1,200,903) | (72,054) | (4,443,340) | (38,523,693) | — | (43,039,087) | — | (43,039,087) |
| Stock-based compensation expense related to stock options, employee stock purchases and restricted stock | — | — | 10,473,792 | — | — | 10,473,792 | — | 10,473,792 |
| Dividends declared ($0.12 per share) | — | — | — | (27,743,481) | — | (27,743,481) | — | (27,743,481) |
| Net income | — | — | — | 108,230,714 | — | 108,230,714 | — | 108,230,714 |
| Other comprehensive loss | — | — | — | — | (909,204) | (909,204) | — | (909,204) |
| BALANCE AS OF MARCH 31, 2024 | 231,198,885 | $13,871,933 | $991,053,652 | $1,378,904,530 | $(7,466,326) | $2,376,363,789 | $— | $2,376,363,789 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.